Search Results
59 items found for "Mou-Wang Zhou"
- 🧠Do you want to share your #GPCR knowledge?
🧠Do you want to share your #GPCR knowledge? Come to Dr.
- Bursicon receptor gene HLGR2 as a potential RNA interference target for control of the fall ...
HLGR2 RNAi led to a low pupation rate (45.00%), body malformation, abnormal wing expansion, failed cuticle Conclusion: HLGR2 is essential for the growth and development and wing expansion and maturation in H.
- Chemokine receptor-targeted drug discovery: progress and challenges
The chemokine receptor system is implicated in a wide range of inflammatory, autoimmune and infectious immunosuppressive tumor microenvironment, and facilitate metastatic spread (Nagarsheth, Wicha, and Zou binding, as well as G-protein coupling or interaction with other signaling molecules (Sohy et al. 2009; Wang protein-protein interactions which are difficult to modulate using small molecules (Sohy et al. 2009; Wang
- Regulators of G-protein signaling: essential players in GPCR signaling
In addition to the RGS domain, RGS proteins also contain a range of other structural motifs that are : Recent studies have revealed that the interaction between RGS proteins and GPCRs is mediated by a range The dysregulation of these proteins has been implicated in a range of diseases, and understanding the Wang, Q., L.Y. Liu-Chen, and J.R. Wang, D., The essential role of G protein-coupled receptor (GPCR) signaling in regulating T cell immunity
- GPCRs are not simple on-off switches: deep dive into GPCR-ligand interactions
GPCRs are present in a range of conformations, and the binding of a ligand, as well as interactions with disruption of natural spatial and temporal signaling patterns regulated by physiological systems (Wold and Zhou intervention for metabolic diseases such as liver disease, obesity and diabetes (Secor et al. 2021; Wold and Zhou desensitization), the same drug acting on the same receptor in the same cellular context can produce a range
- What's Going On with GPCRs?! Find Out in This Week's Update! ⦿ Nov 4 - 10, 2024
Want to know what’s buzzing in the world of GPCRs? a database of binding sites of human G-protein coupled receptors under diverse states Fan Liu , Han Zhou , Xiaonong Li , Liangliang Zhou , Chungong Yu , Haicang Zhang , Dongbo Bu 🤩 Seriously, why would you want to miss out on all the awesomeness that comes with a DrGPCR Premium Membership ?
- Therapeutic validation of an orphan G protein‐coupled receptor
Regarding the first question, GPR84 overexpression in immune cells in a range of pro‐inflammatory disorders indole‐3‐carbinol, which is present at high levels in some vegetables including broccoli and kale (Wang
- Overview of adhesion GPCRs self-activation
., Zhu, X., Wang, N., Xu, Z., Xia, R., Liang, J., Duan, Y., Yin, H., Xiong, Y., Zhang, A., Guo, C., Chen
- Artificial intelligence – faster, smarter, cheaper GPCR drug discovery
to predict subtype-selective ligands for dopamine receptors and adenosine receptors (He, Ben, Kuang, Wang & Kong, 2016; Kuang, Feng, Hu, Wang, He & Kong, 2016). 5.
- VAMP2: a crucial player in the delivery of MOR to the synapse
Wang, F., X. Chen, X. Zhang, and L. Ma. 2008.
- 🤯Mind-blowing GPCR Scoops! Discover the Latest Breakthroughs! ⦿ Nov 18 - 24, 2024
High-affinity agonists reveal recognition motifs for the MRGPRD GPCR Chunyu Wang , Yongfeng Liu , Marion
- Hop in the Time Machine with GPCR: Unraveling the Future of Research! ⦿ Nov 24 - Dec 1, 2024
Calcineurin-fusion facilitates cryo-EM structure determination of a Family A GPCR Jun Xu , Geng Chen , Haoqing Wang , Sheng Cao , Jie Heng , Xavier Deupi , Yang Du , Brian K Kobilka Red and far-red cleavable fluorescent
- Unlocking Cell's Secrets: Spontaneous β-Arrestin-Membrane Preassociation Drives Receptor-Activation
., Wang, J.K., Bauer, B., Townshend, R.J.L., Hollingsworth, S.A., Olivieri, J.E., Xu, H.E., Sommer, M.E
- Illuminating GPCR Research: FRET and BRET-Based Sensors Shed Light on Cellular Signaling
Zhou, Y., et al., Multiple GPCR Functional Assays Based on Resonance Energy Transfer Sensors. Wan, Q., et al., Mini G protein probes for active G protein-coupled receptors (GPCRs) in live cells.
- Targeting Intracellular Allosteric Sites in GPCRs
therapeutic intervention for metabolic diseases such as liver disease, obesity and diabetes (Wold and Zhou
- Feeder or trigger – CCR2 as a scavenger and regulator of cell migration
Wang et al. 2009; R. J.
- An overview of the compartmentalized GPCR Signaling: Relevance and Implications
., Wang, B., Bouley, R., Potts, J. T., Gardella, T. J., & Vilardaga, J. P. (2009).
- ⛵Sailing the GPCR Seas: Your Weekly Research Voyage! ⦿ Nov 11 - 17, 2024
Week’s Highlights: SNX9 family mediates βarrestin-independent GPCR endocytosis Valeria Robleto , Ya Zhuo
- Profiling Immune Cell and Platelet Transcriptomes
The study reports that human white blood cells express an average of 160 GPCR mRNAs, ranging from 123 the insights gained from this research will be instrumental in shaping therapeutic strategies for a range
- Therapeutic validation of an orphan G protein-coupled receptor: The case of GPR84
August 2022 "Despite the importance of members of the GPCR superfamily as targets of a broad range of Expression of GPR84 is strongly up regulated in immune cells in a range of pro-inflammatory settings
- Discovery On Target, October 17-20, 2022, Boston, USA
well as target validation strategies for the discovery and development of novel therapeutic agents ranging
- Obesity-induced changes in human islet G protein-coupled receptor expression: Implications for ...
this review, we have compared expression of GPCR mRNAs in human islets obtained from normal weight range donors, and those with a weight range classified as obese.
- ShouTi Introduces Basecamp Bio as a Wholly Owned Subsidiary to Expand Pipeline and Partnerships
clinical-stage global biopharmaceutical company developing novel oral therapeutics to treat a wide range
- Crinetics Pharmaceuticals announced the formation of an independently operated new company...
develop a deep pipeline of novel, targeted, nonpeptide radiopharmaceuticals for the treatment of a broad range develop a deep pipeline of novel, targeted, nonpeptide radiopharmaceuticals for the treatment of a broad range
- Structural landscape of the Chemokine Receptor system
6P4]CCL5), a chemokine antagonist ([5P7]CCL5), and a small-molecule inverse agonist (maraviroc) (Tan, Zhu activation will pave the way for significant advancements in the development of therapeutics for a wide range
- MSX-122: Is an effective small molecule CXCR4 antagonist in cancer therapy?
cytokines along with their receptors, are involved in various biologic processes and regulation of a wide range
- Verily links up with Sosei Heptares for GPCR drug discovery
recent years as researchers have discovered the vast potential for GPCR-targeting drugs in treating a range
- Decoding β-Arrestins: from Structure to function
detection, receptor activation initiates conformational changes, exposing an intracellular cavity (Kang Despite multifocal signaling, recent studies indicate that signaling occurs within a 100 nm range from high-resolution protein structures, illuminating side chain orientations and overall conformational states (Kang